, Tracking Stock Market Picks
Enter Symbol:
Mednax Inc. (MD) [hlAlert]

Buy MD
up 16.71 %

Mednax Inc. (MD) rated Buy with price target $91 by Stifel

Posted on: Tuesday,  Aug 25, 2015  8:25 AM ET by Stifel

Stifel rated Buy Mednax Inc. (NYSE: MD) on 08/25/2015. Previously Stifel rated Buy Mednax Inc. (NYSE: MD) on 02/06/2015., when
the stock price was $69.87. Since then, Mednax Inc. has gained 16.72% as of 12/30/2015's recent price of $81.55.
If you would have followed the previous Stifel's recommendation on MD, you would have gained 16.71% of your investment in 327 days.

MEDNAX, Inc., (MEDNAX), formerly Pediatrix Medical Group, Inc., is a provider of physician services, including newborn, maternal-fetal, pediatric subspecialty and anesthesia care. As of December 31, 2009, the Company?s national network consisted of 1,484 affiliated physicians, including 928 physicians who provide neonatal clinical care, in 33 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The Company has 168 affiliated physicians who provide maternal-fetal medical care to expectant mothers experiencing complicated pregnancies and obstetrician hospitalist services in many areas where its affiliated neonatal physicians practice. Its network includes other pediatric subspecialists, including 98 physicians providing pediatric cardiology care, 68 physicians providing pediatric intensive care and 36 physicians providing hospital-based pediatric care.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/25/2015 8:25 AM Buy
80.01 91.00
as of 8/27/2015
1 Week down  -3.26 %
1 Month up  10.59 %
3 Months up  15.83 %
1 YTD up  1.92 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/6/2015 8:25 AM Buy
69.87 77.00
11/1/2013 8:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy